Funded studies

Bryn Mawr Hospital

SSRF2019-01 / Michael Ezekowitz, MD. Executive committee: Hans Liu, MD, Michele Columbo, MD. “Creation of a protocol to study non-vitamin K antagonist oral anticoagulants in atrial fibrillation ‘NOW’ Implementation of a protocol to compare three Non-Vitamin K Antagonists in Atrial Fibrillation patients.

SSRF2019-02 / Robert E. Day, MD. Co-investigator: Dmitri Chamchad, MD, and collaborator: Norman Brest, MD. “A Comparison of IV versus PO Acetaminophen Postoperatively for Opioid Consumption After Cesarean Section.

SSRF2019-03 / Lawrence Marinari, MD. Co-investigators: Madeline Danny, DO, Wallace Miller, Jr., MD. “Lower Respiratory Tract Infections Caused by Emerging Viruses: Imaging Patterns and Correlation with Clinical Outcomes.” (People have expressed issues with Dr. Marinari being funded for many years with very little productivity. However, the committee felt that since he wrote and submitted a manuscript this year, they would fund his project even though his project is very similar to previous years.)

SSRF2019-04 / Guy Bernstein, MD. Co-investigator: Laurence Belkoff, DO, Daniel Edwards, DO. “The Utilization of Geographic and Environmental Disparities in the Incidence and Prevalence of Urothelial Carcinoma with Southeastern Pennsylvania to Identify At-Risk Patient Populations and Improve Early Detection.

SSRF2019-05 / Glen Harper, MD. Co-investigator: Michael Ezekowitz, MD. “The characteristics, treatments, and outcomes of patients with nonvalvular atrial fibrillation in a real-world clinical practice: a retrospective analysis between 01/01/11 and 05/30/17.

Lankenau Institute of Medical Research

SSRF2019-08 / Scott Dessain, MD. Support: Cagla Tükel, PhD, Lawrence Livornese, Jr., MD. “An Optimized Human Monoclonal Antibody to Eradicate E. Coli Biofilms.

SSRF2019-12 / Lisa Laury-Kleintop, PhD. Significant contributor: Scott Dessain, MD. “Defining B Cell-Associated Interleukin-1 Receptor Antagonist Expression and Signaling Responses.

SSRF2019-13 / James M. Mullin, PhD. Co-investigator: Bob Etemad, MD. “Reducing Cancer Risk in Barrett’s Esophagus after Radiofrequency Ablation.

SSRF2019-14 / Serge Sicouri, MD. Co-investigators: Konstadinos Plestis, MD, Gan Xi-Yan, MD, and collaborator: Lisa Laury-Kleintop. “Effects of Custodial = HTK Solution on Electrical, Mechanical, Histological and Biochemical Parameters in a Coronary-Perfused Rabbit Ventricular Wedge Model: A Comparison Study.

SSRF2019- 16 / Sunil Thomas, PhD. Co-Investigator: Giancarlo Mercogliano, MD. “Mapping the Cellular and Microbiome Changes in Ulcerative Colitis and During Its Transition to Colorectal Cancer.

SSRF2019- 17 / U. Margaretha Wallon, PhD. Collaborators: Robin Ciocca, DO, Jennifer Sabol, MD, Ned Carp, MD, Vince Ciocca, DO, Laura Mandik-Nayak, PhD. “Systemic Immuneresponses Induced by Cryoablation of Breast Cancer.

SSRF2019- 20 / Kaitlyn Kennard, MD. Co-investigators: Ned Carp, MD, Brad Carter, MD. “Metabolic Syndrome and Breast Cancer- Investigation of Diabetes, NASH and Effect on Breast Cancer Subtypes and Outcomes.” (Dr. Friday was asked by the committee after final decisions were made, to be a collaborator on this project because of his expertise.)

Lankenau Medical Center

SSRF2019- 18 / Gan-Xin Yan, MD, PhD.In Vitro Prediction Model for Drug-Induced QT Prolongation and TdP Risk in Humans: Blinded Validation.

Bryn Mawr Rehabilitation Hospital

SSRF2019-19 / Beth Kolar, DPT. Co-investigator: Kristen McCormick, PT. “Rate of BBPV in Patients Diagnosed with Concussion.